Physician profile
Thomas Santoscoy
NPI 1053376251
$1,005.59
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $122 · 2020: $146 · 2021: $381 · 2022: $23.56 · 2023: $239 · 2024: $93.78.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $332.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $332.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $248.34 | 2020-2024 | Spyglass Discover |
| Innovation Technologies INC | $139.50 | 2023 | Irrisept |
| Pacira Pharmaceuticals Incorporated | $121.75 | 2021 | |
| W. L. Gore & Associates, INC. | $99.00 | 2023 | Gore Enform Preperitoneal Biomaterial |
| Janssen Pharmaceuticals, INC | $69.01 | 2019 | |
| Abbott Laboratories | $44.54 | 2022-2024 | Cardiomems |
| Biodelivery Sciences International, INC. | $38.45 | 2021 | |
| Advanced Respiratory, INC | $34.68 | 2020-2021 | |
| Astrazeneca Pharmaceuticals LP | $34.54 | 2020 | |
| Lilly USA, LLC | $32.52 | 2020-2021 | |
| Collegium Pharmaceutical, INC. | $31.57 | 2021 | |
| Z-Medica, LLC | $29.49 | 2019 | |
| Amgen INC. | $27.98 | 2021 | |
| Ekos Corporation | $23.99 | 2019 | |
| Abbvie INC. | $20.97 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| United Therapeutics Corporation | $9.26 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Santoscoy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.